logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > (4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate CAS 125971-94-0

(4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate CAS 125971-94-0

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 125971-94-0

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:

1

,

3-dioxane-4-acetate CAS 125971-94-0

,

CAS 125971-94-0

CAS NO::
125971-94-0
Appearance::
White To Light Yellow Crystal Powder
Molecular Formula::
C14H23NO4
Molecular Weight::
269.33700
EINECS NO::
425-780-3
MDL NO::
MFCD03093958
CAS NO::
125971-94-0
Appearance::
White To Light Yellow Crystal Powder
Molecular Formula::
C14H23NO4
Molecular Weight::
269.33700
EINECS NO::
425-780-3
MDL NO::
MFCD03093958
(4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate CAS 125971-94-0

Product Description:

Product Name: (4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate CAS NO: 125971-94-0

 

 

Synonyms:

tert-Butyl (4R,6R)-6-CyanoMethyl-2,2-diMethyl-1,3-dioxane-4-acetate;

(4R-cis)-1,1-Dimethylethyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate;

 

 

Chemical & Physical Properties:

Appearance: White to light yellow crystal powder

Assay :≥99.00%

Density: 1.016 g/cm3

Boiling Point: 364.1℃ at 760 mmHg

Melting Point: 65-70℃

Flash Point: 159.2℃

Refractive Index: 1.439

Vapor Pressure: 1.73E-05mmHg at 25℃

 

 

Safety Information:

Safety Statements: S24/25

HS Code: 2932999099

WGK Germany: 3

 

 

(4R,6R)-6-(Cyanomethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester is an intermediate of Atorvastatin (A791750, Ca salt), a selective, competitive HMG-CoA reductase . Atorvastatin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglyceinhibitorrides in patients with hypercholesterolemia.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.